Jointown Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020
October 26, 2020 at 10:00 am
Share
Jointown Pharmaceutical Group Co., Ltd. announced earnings results for the nine months ended September 30, 2020. For the nine months, the company announced sales was CNY 80,319.607 million compared to CNY 73,378.823 million a year ago. Operating income was CNY 3,233.166 million compared to CNY 1,316.832 million a year ago. Net income was CNY 2,141.280 million compared to CNY 1,018.557 million a year ago. Basic earnings per share from continuing operations was CNY 1.17 compared to CNY 0.55 a year ago. Diluted earnings per share from continuing operations was CNY 1.14 compared to CNY 0.54 a year ago.
Jointown Pharmaceutical Group Co., Ltd. is principally engaged in the wholesaling and retailing of pharmaceuticals and medical equipments. The Company is also engaged in the research, development and production of drugs, as well as the provision of relevant value-added services. The Companyâs products mainly include western medicines, proprietary Chinese medicines, Chinese medicine pieces, Chinese herbal medicines, medical equipments, health care products, cosmetics, among others. The Company mainly provides services to direct sales or franchise stores through its retailing businesses.